S268: INTERIM ANALYSIS OF A PHASE 2 TRIAL TO ASSESS THE EFFICACY AND SAFETY OF CRIZANLIZUMAB IN SICKLE CELL DISEASE PATIENTS WITH PRIAPISM (SPARTAN)

ABSTRACT:

SUBMITTER: Anderson A 

PROVIDER: S-EPMC10428507 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature